Metraipolis › archive › dc_ee0e61bde83d
RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma — Europe PMC PMID:41232667
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41232667
- DOI
- 10.1016/j.jbc.2025.110918
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:21:27.967Z
- SHA-256 of the archived text
f114a743d03a1f287a9327ff1f1a8901ef004b1475b01aff8ffe5af1fd159315- Stable URL of this page
https://metraipolis.com/documento/dc_ee0e61bde83d
How to cite
RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma — Europe PMC PMID:41232667 — Europe PMC (en), https://europepmc.org/article/MED/41232667 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee0e61bde83d (Metraipolis archive dc_ee0e61bde83d, sha256 f114a743d03a1f287a9327ff1f1a8901ef004b1475b01aff8ffe5af1fd159315)
BibTeX
@misc{dcee0e61bde83d,
title = {RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma — Europe PMC PMID:41232667},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41232667},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee0e61bde83d; sha256 f114a743d03a1f287a9327ff1f1a8901ef004b1475b01aff8ffe5af1fd159315},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41232667. Agents can read the archived copy with the MCP tool read_document.